John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...

Large primes are promising to invest more money in conjunction with major new missile deals and other U.S. military spending increases. Credit: Lockheed Martin U.S. defense primes are pledging to ...

Blue Owl Capital offers robust margins, stable fee-related earnings, and is structurally positioned for long-term distributable earnings growth. OWL trades at a sub-20x forward multiple despite 45%+ ...

Will you share your thoughts in our annual survey? Never miss a story with The Brief, our free newsletter. Keep tabs on Texas politics and policy with our morning newsletter. The Texas Tribune ...

Just over two weeks into the new year, multiple fast-food and fast-casual chain restaurants across the United States have announced plans to downsize, with some stating they intend to focus resources ...

Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...

Think fast delivery has reached absurd levels in the U.S.? Give a thought to India, where the government has asked all quick-commerce platforms to drop a "10-minute delivery" promise. According to BBC ...

The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first smart MDI system to automatically integrate insulin dosing and glucose data ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

It looks like Elon Musk made a whole lot of 2025 promises that he couldn't keep. Credit: BRENDAN SMIALOWSKI/AFP via Getty Images By now, everyone knows that Elon Musk is very much an optimist when it ...

Wells Fargo initiated coverage of Arcellx (ACLX) with an overweight rating saying that its experimental CAR-T therapy for multiple myeloma, anito-cel, is a "future pillar" in management of the blood ...

A fast charging EV startup is filing for bankruptcy protection amid broader disruption across the electric vehicle industry. San Francisco-based Ample filed for Chapter 11 bankruptcy this week, citing ...